Search by Drug Name or NDC

    NDC 00169-7703-21 Norditropin 30 mg/3mL Details

    Norditropin 30 mg/3mL

    Norditropin is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is SOMATROPIN.

    Product Information

    NDC 00169-7703
    Product ID 0169-7703_f29c93fa-6486-465b-88a9-6c2d984d17f9
    Associated GPIs 3010002000D260
    GCN Sequence Number 065287
    GCN Sequence Number Description somatropin PEN INJCTR 30 MG/3 ML SUBCUT
    HIC3 P1A
    HIC3 Description GROWTH HORMONES
    GCN 25816
    HICL Sequence Number 002824
    HICL Sequence Number Description SOMATROPIN
    Brand/Generic Brand
    Proprietary Name Norditropin
    Proprietary Name Suffix n/a
    Non-Proprietary Name somatropin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 30
    Active Ingredient Units mg/3mL
    Substance Name SOMATROPIN
    Labeler Name Novo Nordisk
    Pharmaceutical Class Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA021148
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-7703-21 (00169770321)

    NDC Package Code 0169-7703-21
    Billing NDC 00169770321
    Package 1 SYRINGE in 1 CARTON (0169-7703-21) / 3 mL in 1 SYRINGE
    Marketing Start Date 2015-01-23
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 1058e17c-9261-459c-a3e6-fae38d196c14 Details

    Revised: 3/2020